Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-01 Sale |
2023-11-02 4:49 pm |
Tango Therapeutics Inc. | TNGX | Crystal Adam See Remarks |
7,507 | $8.3914 | $62,994 | 81,250 (Direct) |
View |
| 2023-10-13 Purchase(A) |
2023-10-17 7:41 pm |
Tango Therapeutics Inc. | TNGX | Boxer Capital LLC Davis Aaron I. LEWIS JOSEPH MVA Investors LLC Boxer Asset Management Inc. See remarks |
1,250,000 | $6.978 | $8,722,500 | 15,912,577 (Indirect Direct) |
View |
| 2023-10-13 Purchase |
2023-10-17 6:04 pm |
Tango Therapeutics Inc. | TNGX | Boxer Capital LLC Davis Aaron I. LEWIS JOSEPH MVA Investors LLC Boxer Asset Management Inc. See remarks |
1,250,000 | $6.978 | $8,722,500 | 15,912,577 (Indirect Direct) |
View |
| 2023-10-09 Sale |
2023-10-11 9:22 pm |
Tango Therapeutics Inc. | TNGX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. See remarks |
225,000 | $9.9567 | $2,240,250 | 14,662,577 (Indirect Direct) |
View |
| 2023-08-11 Purchase |
2023-08-15 9:34 pm |
Tango Therapeutics Inc. | TNGX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. See remarks |
475,000 | $5.15 | $2,446,250 | 17,228,192 (Indirect Direct) |
View |
| 2022-10-11 Purchase |
2022-10-13 9:30 pm |
Tango Therapeutics Inc. | TNGX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. 10% Owner |
237,000 | $4.4075 | $1,044,573 | 7,123,642 (Direct) |
View |
| 2022-10-04 Purchase |
2022-10-06 9:15 pm |
Tango Therapeutics Inc. | TNGX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH 10% Owner |
182,000 | $3.9236 | $714,096 | 7,053,642 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-01 Option Award |
2024-02-05 4:22 pm |
N/A 2034-02-01 |
Tango Therapeutics Inc. | TNGX | Crystal Adam See Remarks |
326,192 | $0 | 326,192 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 4:21 pm |
N/A 2034-02-01 |
Tango Therapeutics Inc. | TNGX | Weber Barbara Chief Executive Officer |
610,180 | $0 | 610,180 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 4:19 pm |
N/A 2034-02-01 |
Tango Therapeutics Inc. | TNGX | Barry Douglas General Counsel |
160,015 | $0 | 160,015 (Direct) |
View |
Ownership |
2023-10-16 3:42 pm |
N/A N/A |
Tango Therapeutics Inc. | TNGX | EcoR1 Capital LLC 10% Owner |
0 | $0 | 13,330,736 (Indirect) |
View |
| 2023-08-11 Option Award(A) |
2023-10-11 7:22 pm |
N/A N/A |
Tango Therapeutics Inc. | TNGX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. See remarks |
2,340,579 | $5.1499 | 17,228,174 (Direct) |
View |
| 2023-08-11 Option Award(A) |
2023-10-11 7:22 pm |
N/A N/A |
Tango Therapeutics Inc. | TNGX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. See remarks |
475,000 | $5.15 | 17,228,174 (Indirect) |
View |
| 2023-08-29 Option Award |
2023-08-31 4:07 pm |
N/A 2033-08-29 |
Tango Therapeutics Inc. | TNGX | Ketchum John B Director |
70,000 | $0 | 70,000 (Direct) |
View |
Ownership |
2023-08-22 4:15 pm |
N/A N/A |
Tango Therapeutics Inc. | TNGX | Third Rock Ventures VI L.P. Third Rock Ventures GP VI L.P. TRV GP VI LLC Director |
0 | $0 | 194,174 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 9:40 pm |
N/A 2033-06-06 |
Tango Therapeutics Inc. | TNGX | Rothenberg Mace Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 9:39 pm |
N/A 2033-06-06 |
Tango Therapeutics Inc. | TNGX | Calhoun Lesley Ann Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 9:36 pm |
N/A 2033-06-06 |
Tango Therapeutics Inc. | TNGX | Borisy Alexis Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 9:34 pm |
N/A 2033-06-06 |
Tango Therapeutics Inc. | TNGX | Huber Reid M Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 9:33 pm |
N/A 2033-06-06 |
Tango Therapeutics Inc. | TNGX | Peters Malte Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 9:32 pm |
N/A 2023-06-06 |
Tango Therapeutics Inc. | TNGX | Davis Aaron I. Director |
35,000 | $0 | 14,415,616 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-02 4:10 pm |
N/A 2033-03-01 |
Tango Therapeutics Inc. | TNGX | Crystal Adam See Remarks |
568,750 | $0 | 568,750 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-02 4:06 pm |
N/A 2033-03-01 |
Tango Therapeutics Inc. | TNGX | Weber Barbara Chief Executive Officer |
626,818 | $0 | 1,994,410 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-02 4:06 pm |
N/A 2033-03-01 |
Tango Therapeutics Inc. | TNGX | Beckman Daniella Chief Financial Officer |
229,893 | $0 | 293,760 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-02 4:06 pm |
N/A 2033-03-01 |
Tango Therapeutics Inc. | TNGX | Barry Douglas General Counsel |
167,289 | $0 | 167,289 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-02 4:05 pm |
N/A 2033-03-01 |
Tango Therapeutics Inc. | TNGX | Huang Alan Chief Scientific Officer |
221,878 | $0 | 357,765 (Direct) |
View |
| 2022-12-01 Option Award |
2022-12-05 4:10 pm |
N/A 2032-12-01 |
Tango Therapeutics Inc. | TNGX | Weitzman Aaron Chief Medical Officer |
350,000 | $0 | 350,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-28 4:31 pm |
N/A 2032-06-08 |
Tango Therapeutics Inc. | TNGX | Borisy Alexis Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-28 4:30 pm |
N/A 2032-06-08 |
Tango Therapeutics Inc. | TNGX | Davis Aaron I. Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-28 4:29 pm |
N/A 2032-06-08 |
Tango Therapeutics Inc. | TNGX | Peters Malte Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-28 4:28 pm |
N/A 2032-06-08 |
Tango Therapeutics Inc. | TNGX | Calhoun Lesley Ann Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-28 4:27 pm |
N/A 2032-06-08 |
Tango Therapeutics Inc. | TNGX | Rothenberg Mace Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-28 4:27 pm |
N/A 2032-06-08 |
Tango Therapeutics Inc. | TNGX | Huber Reid M Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:30 pm |
N/A 2032-02-01 |
Tango Therapeutics Inc. | TNGX | Barry Douglas General Counsel |
69,500 | $0 | 69,500 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:30 pm |
N/A 2032-02-01 |
Tango Therapeutics Inc. | TNGX | Weber Barbara Chief Executive Officer |
625,000 | $0 | 625,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:30 pm |
N/A 2032-02-01 |
Tango Therapeutics Inc. | TNGX | Beckman Daniella Chief Financial Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:30 pm |
N/A 2032-02-01 |
Tango Therapeutics Inc. | TNGX | Huang Alan Chief Scientific Officer |
200,000 | $0 | 200,000 (Direct) |
View |